MODULATION OF IMMUNE FUNCTION OCCURS WITHIN HOURS OF THERAPY INITIATION FOR MULTIPLE SCLEROSIS

Daily administration of FDA-approved glatiramer acetate (GA) has beneficial effects on clinical course of relapsing remitting multiple sclerosis (RRMS). Although mechanisms of GA-action have been widely investigated and partially understood, immediate immune dynamics following GA-therapy are unknown...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ayers, Chris L., Mendoza, Jason P., Sinha, Sushmita, Cunnusamy, Khrishen, Greenberg, Benjamin M., Frohman, Elliot M., Karandikar, Nitin J.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3634883/
https://ncbi.nlm.nih.gov/pubmed/23578552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2013.02.015
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares